Study details
Enrolling now
Prospective IR-led Sedation Feasibility
CAMC Health System
NCT IDNCT07443254ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Ages
18+
Locations
1 site in WV
About this study
This Phase 1/Phase 2 study is testing Fentanyl (IV) in people with anesthesia.
Based on ClinicalTrials.gov records.
PhasePhase 1/Phase 2
DrugFentanyl (IV)
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
fentanyl, midazolam (Benzodiazepine; short-acting), ketamine (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)
Drug routes
oral (Oral Lozenge), infusion, injection
Endpoints
Secondary: Patient Satisfaction, Patient-Reported Pain, Sedation-Related Adverse Events